The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the FTSE Developed Choice Index (the “Index”).
The Index is a market-capitalisation-weighted index of common stock of large and mid-sized companies in developed countries.
Through the screening out of stocks of companies from its portfolio based on the potentially detrimental impact of the issuer's conduct or products on society, the Fund promotes certain social characteristics relating to social norms and standards.
The Fund attempts to: 1. Match the risk factor exposures of the Index by investing in a representative sample of the securities that make up the Index, excluding Index constituents that are issued by companies which (as determined by the Index provider) are involved in certain business activities related to (1) chemical and biological weapons, (2) cluster munitions, (3) anti-personnel landmines, (4) nuclear weapons, and/or (5) manufacture and distribution of tobacco products. The screening process also seeks to exclude Index constituents that are issued by companies based on certain controversial conduct, which is achieved by excluding companies that have been deemed ‘Non-Compliant’ in relation to the United Nations Global Compact Principles regarding labour, human rights, environmental, and anti-corruption standards through third party data which is utilised by the Index provider. 2. Remain fully invested except in extraordinary market, political or similar conditions where the Fund may temporarily depart from this investment policy to avoid losses.
Company product and conduct involvement is monitored on a yearly basis by the Index provider and as new data is made available to the Index provider.
For the full investment strategy please review the prospectus.
Fund facts
Share class inception
Minimum initial investment
Investment structure
Share Class Assets'
Total Assets
Strategy
Asset Class
Domicile
Dividend schedule
Legal entity
Benchmark
Register countries
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Performance
Risk and Volatility
-
Sorry, this information is not available yet. It will display a year after inception date.
Please note Beta and R-squared data will only display for funds with 3 full years of history.
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Portfolio data
Characteristics
Fundamentals
Fund
Benchmark
As at
Number of stocks
—
Median market capital
—
—
—
—
—
Portfolio turnover rate
—
Market allocation
As at 28 Feb 2026
Country
Region
Fund
Benchmark
Variance +/-
United States of America
North America
66.54%
66.83%
-0.29%
Japan
Pacific
7.16%
7.05%
0.11%
United Kingdom
Europe
3.80%
3.92%
-0.12%
Canada
North America
3.51%
3.43%
0.08%
Switzerland
Europe
2.57%
2.50%
0.07%
Germany
Europe
2.46%
2.33%
0.13%
South Korea
Pacific
2.44%
2.50%
-0.06%
France
Europe
2.37%
2.60%
-0.23%
Australia
Pacific
1.90%
1.94%
-0.04%
Netherlands
Europe
1.22%
1.29%
-0.07%
Spain
Europe
1.04%
0.97%
0.07%
Italy
Europe
0.87%
0.88%
-0.01%
Sweden
Europe
0.84%
0.91%
-0.07%
Hong Kong
Pacific
0.68%
0.59%
0.09%
Singapore
Pacific
0.39%
0.39%
0.00%
Holdings details
As at 28 Feb 2026
Holding name
% of market value
Sector
Region
Market value
Shares
NVIDIA Corp
4.68494%
Technology
US
€50,739,640.37
338,102
Apple Inc
4.34873%
Technology
US
€47,098,414.04
210,497
Microsoft Corp
3.30868%
Technology
US
€35,834,240.25
107,729
Amazon.com Inc
2.28490%
Consumer Discretionary
US
€24,746,277.63
139,133
Alphabet Inc
1.96485%
Technology
US
€21,280,055.83
80,592
Alphabet Inc
1.75617%
Technology
US
€19,019,993.11
72,109
Broadcom Inc
1.66872%
Technology
US
€18,072,829.97
66,777
Meta Platforms Inc
1.59832%
Technology
US
€17,310,419.04
31,532
Tesla Inc
1.28439%
Consumer Discretionary
US
€13,910,407.42
40,804
Eli Lilly & Co
0.96212%
Health Care
US
€10,420,109.30
11,695
Prices and distribution
Prices
NAV Price (EUR)
€205.03
Change
+€2.951.46%
At closure 01 Apr 2026
NAV 52-week high
€216.50
At closure 04 Apr 2026
NAV 52-week low
€156.04
At closure 04 Apr 2026
NAV 52-week difference
€60.46
Change
+27.93%
At closure 04 Apr 2026
Historical Prices
-
Inception date
31 Jan 2018
Date
NAV (EUR)
01 Apr 2026
€205.0256
31 Mar 2026
€202.0770
30 Mar 2026
€197.9228
27 Mar 2026
€198.6517
26 Mar 2026
€201.3480
25 Mar 2026
€204.5630
24 Mar 2026
€202.6918
23 Mar 2026
€202.6209
20 Mar 2026
€201.5881
19 Mar 2026
€204.4238
Distribution history
Distribution frequency
—
Historical performance 28 Feb 2026
1.53%
All dividends are reinvested for the "Accumulation" shares.
Purchase information
Currency
Base currency: EUR
Fund codes
Bloomberg: VGDWIBH
Citi: OG7M
ISIN: IE00BDZYMK13
MEX ID: VRJNA
SEDOL: BDZYMK1
Product Detail Meta data: Author mode
Port Id:9895
Product Type: mf
Author Environment: true
The sum of investment management fees (the fees paid to the portfolio manager to invest your money and manage the fund) and administrative and other expenses (which cover all costs and expenses connected with the operation of the fund, which includes administrative fees, shareholder's registration and transfer agency fees, custody fees and all other operating expenses).
The share price of a stock divided by its per-share earnings over the past year. For a portfolio, the weighted average P/E ratio of the stocks in the portfolio. P/E is a good indicator of market expectations about a company's prospects; the higher the P/E, the greater the expectations for a company's future growth in earnings.
The price per share of a stock divided by its book value (i.e., net worth) per share. For a portfolio, the ratio is the weighted average price/book ratio of the stocks it holds.
An amount, expressed as a percentage, earned on a company's common stock investment for a specific time frame. This figure tells shareholders how effectively their money is being utilised.
The average annual rate of growth in earnings over the past five years for the stocks in a portfolio.